HLA-associated outcomes in peanut oral immunotherapy trials identify mechanistic and clinical determinants of therapeutic success.

Saved in:
Bibliographic Details
Title: HLA-associated outcomes in peanut oral immunotherapy trials identify mechanistic and clinical determinants of therapeutic success.
Authors: Kanchan K; Division of Allergy and Clinical Immunology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States., Shankar G; Division of Allergy and Clinical Immunology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States., Huffaker MF; The Immune Tolerance Network, San Francisco, CA, United States., Bahnson HT; The Immune Tolerance Network, Seattle, WA, United States.; Benaroya Research Institute at Virginia Mason, Seattle, WA, United States., Chinthrajah RS; Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Palo Alto, CA, United States., Sanda S; The Immune Tolerance Network, San Francisco, CA, United States., Manohar M; Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Palo Alto, CA, United States., Ling H; Institute of Genetic Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States., Paschall JE; Institute of Genetic Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States., Toit GD; The Department of Pediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London, and Guy's and St Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom., Ruczinski I; Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States., Togias A; Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States., Lack G; The Department of Pediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London, and Guy's and St Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom., Nadeau KC; Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Palo Alto, CA, United States., Jones SM; Department of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, AR, United States., Nepom GT; The Immune Tolerance Network, Seattle, WA, United States.; Benaroya Research Institute at Virginia Mason, Seattle, WA, United States., Mathias RA; Division of Allergy and Clinical Immunology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States.
Source: Frontiers in immunology [Front Immunol] 2022 Nov 18; Vol. 13, pp. 941839. Date of Electronic Publication: 2022 Nov 18 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2022.941839